This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Should Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JSMD
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
by Zacks Equity Research
Elevance Health, Medpace and Doximity are part of the Zacks Industry Outlook article.
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
by Urmimala Biswas
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most. However, staffing shortages continue to put brakes on growth.
Medpace (MEDP) Beats Q1 Earnings Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 30.61% and 0.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
by Zacks Equity Research
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why HCA Healthcare (HCA) is a Smart Addition to Your Portfolio
by Zacks Equity Research
HCA Healthcare (HCA) remains well-poised for growth on growing patient volumes, buyouts, effective telehealth services and a notable financial stand.
Why You Should Add Ensign Group (ENSG) to Your Portfolio Now
by Zacks Equity Research
Ensign Group (ENSG) remains well-poised for growth on sustained top-line growth, a growing healthcare portfolio and solid operating cash flows.
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
by Zacks Equity Research
Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Sharecare, Inc. (SHCR) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sharecare (SHCR) delivered earnings and revenue surprises of -200% and 7.56%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Reasons to Add Cencora (COR) Stock in Your Portfolio Now
by Zacks Equity Research
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Universal Health (UHS) remains well-poised for growth on growing patient volumes at its acute care and behavioral healthcare facilities, acquisitions and a commendable financial stand.
Brookdale (BKD) February 2024 Weighted Average Occupancy Rises
by Zacks Equity Research
Brookdale (BKD) witnesses a continuous streak of 28 months of year-over-year improvements in the weighted average occupancy level.
Is Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JSMD
Cigna (CI) Unveils Updated Long-Term Growth Targets & Solutions
by Zacks Equity Research
Cigna (CI) currently estimates long-term average annual adjusted EPS growth within 10-14%. It also came up with new solutions to better manage the rising GLP-1 costs and expand behavioral care.
Community Health (CYH), Cost Plus Drugs Unite to Lower Drug Cost
by Zacks Equity Research
Community Health (CYH) collaborates with Cost Plus Drug to reduce drug costs and shortages.
Zacks.com featured highlights Trip.com Group, Medpace, Centrus Energy and NVIDIA
by Zacks Equity Research
Trip.com Group, Medpace, Centrus Energy and NVIDIA have been highlighted in this Screen of The Week article.
Ensign Group (ENSG) Buys Nursing Units, Boosts U.S. Footprint
by Zacks Equity Research
Ensign Group (ENSG) acquires two skilled nursing facilities in Colorado and one similar facility in Kansas to better serve the regions' patients and grow its healthcare portfolio.
4 Best Profitable Stocks to Invest in Using Net Income Ratio
by Tirthankar Chakraborty
Trip.com Group Limited (TCOM), Medpace (MEDP), Centrus Energy (LEU) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.